- Home
- XENE vs RYAN Comparison
XENE vs RYAN Comparison
Compare XENE & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | RYAN |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.6B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XENE | RYAN |
|---|---|---|
| Price | $60.71 | $41.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $68.55 | $50.88 |
| AVG Volume (30 Days) | 1.5M | ★ 2.8M |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $311,000.00 | ★ $3,051,126,000.00 |
| Revenue This Year | N/A | $15.78 |
| Revenue Next Year | $2,496.48 | $12.49 |
| P/E Ratio | ★ N/A | $86.72 |
| Revenue Growth | N/A | ★ 21.28 |
| 52 Week Low | $30.00 | $29.28 |
| 52 Week High | $62.91 | $67.70 |
Technical Indicators
Market Signals| Indicator | XENE | RYAN |
|---|---|---|
| Relative Strength Index (RSI) | 74.22 | 72.04 |
| Support Level | $52.40 | $37.43 |
| Resistance Level | $62.91 | $59.01 |
| Average True Range (ATR) | 1.75 | 1.69 |
| MACD | 0.93 | 0.68 |
| Stochastic Oscillator | 93.36 | 99.78 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.